Icodec insulin - revolution in diabetes type 2 insulin therapy
Introduction: Basal glucose control in diabetes type 2 is commonly maintained by a single, once-daily administration of insulin through subcutaneous injection. Insulin icodec, a novel ultralong-acting lipidated analog validates the concept of a once-weekly basal injection that is less burdensome, y...
Main Authors: | , , , , , |
---|---|
Format: | Article |
Language: | English |
Published: |
Kazimierz Wielki University
2022-08-01
|
Series: | Journal of Education, Health and Sport |
Subjects: | |
Online Access: | https://apcz.umk.pl/JEHS/article/view/39466 |